Announcements Trials
Browse Landscape

Phase

Phase 1 40Phase 1/2 27Phase 2 19Phase EARLY_PHASE1 15Phase NA 6Phase 4 3Phase 3 3Phase 2/3 1

Status

Unknown 3Recruiting 3Not yet recruiting 2Completed 1Active not recruiting 1

Sponsor Class

OTHER_GOV 2OTHER 1

Study Type

Interventional 3

Sponsor

Cancer Type

Lymphoid 3

Conditions

Breast Neoplasms 55Carcinoma, Hepatocellular 40Neoplasms 38Polycystic Ovary Syndrome 27Colorectal Neoplasms 24Stomach Neoplasms 21Precursor Cell Lymphoblastic Leukemia-Lymphoma 17Prostatic Neoplasms 16Carcinoma, Non-Small-Cell Lung 16Recurrence 13Pancreatic Neoplasms 13Lymphoma 13Liver Neoplasms 13Urinary Bladder Neoplasms 11Leukemia, Myeloid, Acute 11Esophageal Neoplasms 11Leiomyoma 10Colonic Neoplasms 10Pain 9Lung Neoplasms 9Multiple Myeloma 8Uterine Cervical Neoplasms 7Neoplasm Metastasis 7Lymphoma, Non-Hodgkin 7Lymphoma, Follicular 7Keratosis, Actinic 7Infertility 7Papillomavirus Infections 6Pain, Postoperative 6Leukemia, Myelogenous, Chronic, BCR-ABL Positive 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 4 × Unknown × Lymphoma, B-Cell × Clear all
NCT04152577 2019-11-05

R2 and Combination Chemotherapy Versus R and Combination Chemotherapy in Newly Diagnosed Highly Aggressive B-NHL

Shandong Provincial Hospital

Phase 4 Unknown
200 enrolled
Lymphoid

Lymphoma, B-Cell

NCT02996617 2016-12-19

PEG-rhG-CSF in Patients With Non-Hodgkin Lymphoma Receiving Chemotherapy to Prevent Neutropenia

Shandong Provincial Hospital

Phase 4 Unknown
240 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Neutropenia, Lymphoma, B-Cell, Lymphoma, T-Cell

NCT02992834 2016-12-14

Anti-CD19:TCRζ Chimeric Antigen Receptor-T Cells in the Treatment for CD19+ B Cell Lymphoma

The First People's Hospital of Changzhou

Phase 4 Unknown
10 enrolled
Lymphoid

Lymphoma, B-Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡